CompletedPhase 1NCT01734889
Taste and Palatability of Orfadin Suspension
Studying Tyrosinemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Swedish Orphan Biovitrum
- Principal Investigator
- Erik Brouwer, MDSwedish Orphan Biovitrum
- Intervention
- Nitisinone(drug)
- Enrollment
- 18 enrolled
- Eligibility
- 17 years · All sexes
- Timeline
- 2012 – 2013
Study locations (7)
- Hopital Necker, Paris, France
- Universitätsklinikum Düsseldorf, Düsseldorf, Germany
- Universitätsklinikum Heidelberg, Heidelberg, Germany
- Klinikum der Universität München, München, Germany
- Birmingham Children's Hospital, Birmingham, United Kingdom
- Evelina Children's Hospital, St Thomas' Hospital, London, United Kingdom
- St Mary's Hospital, Manchester, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01734889 on ClinicalTrials.gov